GlaxoSmithKline Pharmaceuticals Announces Board Meeting to Review Q1 Financial Results
GlaxoSmithKline Pharmaceuticals Ltd has scheduled a meeting of its Board of Directors to review the company's performance for the first quarter of the fiscal year. The board meeting is set to take place on Monday, August 3, 2026.The primary agenda item for the meeting includes considering and approving the un-audited financial results for the first quarter that ended on June 30, 2026. This review is intended to ensure proper recording of the company's Q1 performance.
GLAXO Stock Price Movement
As of 12:24 PM, GlaxoSmithKline Pharmaceuticals Limited sheds 0.49% in live trading, slipping by ₹12.10 to currently trade at ₹2471. The stock has seen a total volume of 13,469 shares throughout the current market phase.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.